References
- Bereket A, Erdogan T. Oral bisphosphonate therapy for vitamin D intoxication of the infant. Pediatrics 2003; 111: 899–901
- Kohane D, Tobin J, Kohane I. Endocrine, mineral, and metabolic disease in pediatric intensive care. Textbook of Pediatric Intensive Care, M.C Rogers, DG Nichols. Lippincott Williams & Wilkins, Philedelphia 1996
- Lteif AN, Zimmerman D. Bisphosphonates for treatment of childhood hypercalcemia. Pediatrics 1998; 102: 990–993
- Srivastava T, Alon US. The role of bisphosphonates in diseases of childhood. Eur J Pediatr 2003; 162: 735–751
- Seikaly MG, Baum M. Thiazide diuretics arrest the progression of nephrocalcinosis in children with X-linked hypophosphatemia. Pediatrics 2001; 108: E6
- Cesur Y, Caksen H, Gundem A, Kirimi E, Odabas D. Comparison of low and high dose of vitamin D treatment in nutritional vitamin D deficiency rickets. J Pediatr Endocrinol Metab 2003; 16: 1105–1109
- Greenbaum LA. Electrolyte and Acid-Base Disorders. Nelson Textbook of Pediatrics, R.E Behrman, R.M Kliegman, H.B Jenson. WB Saunders, Philadelphia 2004
- Selby PL, Davies M, Marks JS, Mawer EB. Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate. Clin Endocrinol (Oxf) 1995; 43: 531–536
- Gonzalez-Moles MA, Bagan-Sebastian JV. Alendronate-related oral mucosa ulcerations. J Oral Pathol Med 2000; 29: 514–518
- Demerjian N, Bolla G, Spreux A. Severe oral ulcerations induced by alendronate. Clin Rheumatol 1999; 18: 349–350
- Elliott SN, McKnight W, Davies NM, MacNaughton WK, Wallace JL. Alendronate induces gastric injury and delays ulcer healing in rodents. Life Sci 1998; 62: 77–91
- Wilkes-Holmes C. Safe placement of nasogastric tubes in children. Paediatr Nurs 2006; 18: 14–17
- Atabek ME, Pirgon O, Sert A. Oral alendronate therapy for severe vitamin D intoxication of the infant with nephrocalcinosis. J Pediatr Endocrinol Metab 2006; 19: 169–172
- Unal E, Abaci A, Bober E, Buyukgebiz A. Efficacy and safety of oral alendronate treatment in children and adolescents with osteoporosis. J Pediatr Endocrinol Metab 2006; 19: 523–528